Content of BB platelet growth factor in platelet lysates obtained from donor blood
- 作者: Shupletsova V.V.1, Khaziakhmatova O.G.1, Malashchenko V.V.1, Borisenko S.L.2, Gabrelyan N.V.1, Umarova M.M.1, Goncharov A.G.1, Litvinova L.S.1
-
隶属关系:
- Immanuel Kant Baltic Federal University
- Blood Transfusion Station of the Kaliningrad Region
- 期: 卷 28, 编号 2 (2025)
- 页面: 171-176
- 栏目: SHORT COMMUNICATIONS
- URL: https://bakhtiniada.ru/1028-7221/article/view/284804
- DOI: https://doi.org/10.46235/1028-7221-17025-COB
- ID: 284804
如何引用文章
全文:
详细
Cell therapy is among the main methodological approaches in regenerative medicine. Its effectiveness is determined by the use of cell cultures containing the largest available number of viable cells. An important role in this process is played by growth factors that ensure cell proliferation and differentiation. Both recombinant proteins and native proteins from various biological fluids may be used as growth factors. Blood platelets, being anucleate cells, are a promising source of growth factors. Along with their main blood clotting function, the platelets contain a number of unique biological molecules in alpha granules, i.e., mediators involved in immune response, inflammation and regeneration processes. The major families of growth factors present in platelets are: platelet-derived growth factors (PDGF), transforming growth factors (TGF-β), vascular endothelial growth factors (VEGF), epithelial growth factors (EGF), fibroblast growth factors (FGF), insulin-like growth factors (IGFs). The PDGF family includes several subtypes: PDGF-AA, PDGF-BB, PDGF-AB, PDGF-CC, PDGF-DD. PDGF-BB has high angiogenic, chemotactic and mitogenic activity. It takes part in the proliferation and migration of interstitial cells in various organs, proliferation of smooth muscle cells in respiratory tract, development of cerebral vessels and renal glomeruli. The aim of our study was to examine the content of PDGF-BB factor in platelet lysates obtained from healthy donors. Platelet lysate is a complex cocktail containing many growth factors, cytokines, and chemokines. The concentration of specific factors in final product obtained from platelet concentrate is different for each donor, and, apparently, depends on age, gender, blood type and other individual differences. When choosing a growth additive for a cell culture, the cell biologist should be focused on high content of the trophic factor that most closely matches the goals of the given experiment. The use of recombinant additives in the culture medium is justified by precise dosage of these components. However, the use of natural sources may be more preferable, due to presence of different growth factors required for in vitro expansion of highly cellular viable cultures. According to our results, the optimal additive for obtaining viable fibroblasts, endothelial cells, mesenchymal multipotent stem cells is a growth-inducing product obtained from platelet lysate of female donors of Bα (III) group, and male donors of Aβ (II) blood groups which contain the highest concentration of PDGF-BB.
作者简介
V. Shupletsova
Immanuel Kant Baltic Federal University
编辑信件的主要联系方式.
Email: vshupletsova@mail.ru
PhD (Biology), Senior Researcher, Center for Immunology and Cellular Biotechnologies
俄罗斯联邦, KaliningradO. Khaziakhmatova
Immanuel Kant Baltic Federal University
Email: vshupletsova@mail.ru
PhD (Biology), Senior Researcher, Center for Immunology and Cellular Biotechnologies
俄罗斯联邦, KaliningradV. Malashchenko
Immanuel Kant Baltic Federal University
Email: vshupletsova@mail.ru
PhD (Biology), Researcher, Center for Immunology and Cellular Biotechnologies
俄罗斯联邦, KaliningradS. Borisenko
Blood Transfusion Station of the Kaliningrad Region
Email: vshupletsova@mail.ru
Software Engineer
俄罗斯联邦, KaliningradN. Gabrelyan
Immanuel Kant Baltic Federal University
Email: vshupletsova@mail.ru
Master’s Student, Institute of Medicine and Life Sciences
俄罗斯联邦, KaliningradM. Umarova
Immanuel Kant Baltic Federal University
Email: vshupletsova@mail.ru
Master’s Student, Institute of Medicine and Life Sciences
俄罗斯联邦, KaliningradA. Goncharov
Immanuel Kant Baltic Federal University
Email: vshupletsova@mail.ru
PhD (Medicine), Senior Researcher, Center for Immunology and Cellular Biotechnologies
俄罗斯联邦, KaliningradL. Litvinova
Immanuel Kant Baltic Federal University
Email: vshupletsova@mail.ru
PhD, MD (Medicine), Director, Center for Immunology and Cellular Biotechnologies
俄罗斯联邦, Kaliningrad参考
- Василевич Н.И., Честков В.В. Бессывороточные питательные среды: научные, этические и биотехнологические аспекты // Лаборатория и производство, 2019. № 6 (10). С. 64-71. [Vasilevich N.I., Chestkov V.V. Serum-free nutrient media: scientific, ethical and biotechnological aspects. Laboratoriya i proizvodstvo = Laboratory and Production, 2019, no. 6 (10), pp. 64-71. (In Russ.)]
- Ткачук В.А. Регенеративная биомедицина в биологии и медицине // Регенерация органов и тканей, 2023. Т. 1, № 1. С. 7-15. [Tkachuk V.A. Regenerative biomedicine in biology and medicine. Regeneratsiya organov i tkaney = Regeneration of Organs and Tissues, 2023, Vol. 1, no. 1, pp. 7-15. (In Russ.)]
- Ai J.Y., Liu C.F., Zhang W., Rao G.W. Current status of drugs targeting PDGF/PDGFR. Drug Discov. Today, 2024, Vol. 29, no. 7, 103989. doi: 10.1016/j.drudis.2024.103989.
- Burnouf T., Chou M.L., Lundy D.J., Chuang E.Y., Tseng C.L., Goubran H. Expanding applications of allogeneic platelets, platelet lysates, and platelet extracellular vesicles in cell therapy, regenerative medicine, and targeted drug delivery. J. Biomed. Sci., 2023, Vol. 30, no. 1, 79. doi: 10.1186/s12929-023-00972-w.
- Cao Z., Liu Y., Wang Y., Leng P. Research progress on the role of PDGF/PDGFR in type 2 diabetes. Biomed. Pharmacother., 2023, Vol. 164, 114983. doi: 10.1016/j.biopha.2023.114983.
- Chen M., Chang C., Levian B., Woodley D.T., Li W. Why are there so few FDA-approved therapeutics for wound healing? Int. J. Mol. Sci., 2023, Vol. 24, no. 20, 15109. doi: 10.3390/ijms242015109.
- Fredriksson L., Li H., Eriksson U. The PDGF family: four gene products form five dimeric isoforms. Cytokine Growth Factor Rev., 2004, Vol. 15, no. 4, pp. 197-204.
- Galarraga-Vinueza M.E., Barootchi S., Nevins M.L., Nevins M., Miron R.J., Tavelli L. Twenty-five years of recombinant human growth factors rhPDGF-BB and rhBMP-2 in oral hard and soft tissue regeneration. Periodontol. 2000, 2024, Vol. 94, no. 1, pp. 483-509.
- Jahanseir K., Xing D., Greipp P.T., Sukov W.R., Keeney G.L., Howitt B.E., Schoolmeester J.K. PDGFB Rearrangements in dermatofibrosarcoma protuberans of the vulva: a study of 11 cases including myxoid and fibrosarcomatous variants. Int. J. Gynecol. Pathol., 2018, Vol. 37, no. 6, pp. 537-546.
- Mihaylova Z., Tsikandelova R., Sanimirov P., Gateva N., Mitev V., Ishkitiev N. Role of PDGF-BB in proliferation, differentiation and maintaining stem cell properties of PDL cells in vitro. Arch. Oral Biol., 2018, Vol. 85, pp. 1-9.
- Patenall B.L., Carter K.A., Ramsey M.R. Kick-starting wound healing: a review of pro-healing drugs. Int. J. Mol. Sci., 2024, Vol. 25, no. 2, 1304. doi: 10.3390/ijms25021304.
- Price P.J. Best practices for media selection for mammalian cells. In vitro Cell. Dev. Biol. Anim., 2017, Vol. 53, no. 8, pp. 673-681.
- Sekine S.I., Kaneko M., Tanaka M., Ninomiya Y., Kurita H., Inden M., Yamada M., Hayashi Y., Inuzuka T., Mitsui J., Ishiura H., Iwata A., Fujigasaki H., Tamaki H., Tamaki R., Kito S., Taguchi Y., Tanaka K., Atsuta N., Sobue G., Kondo T., Inoue H., Tsuji S., Hozumi I. Functional evaluation of PDGFB-variants in idiopathic basal ganglia calcification, using patient-derived iPS cells. Sci. Rep., 2019, Vol. 9, no. 1, 5698. doi: 10.1038/s41598-019-42115-y.
- Wang C., Ma X., Xu X., Huang B., Sun H., Li L., Zhang M., Liu J.Y. A PDGFB mutation causes paroxysmal nonkinesigenic dyskinesia with brain calcification. Mov. Disord., 2017, Vol. 32, no. 7, pp. 1104-1106.
- Yao T., Asayama Y. Animal-cell culture media: History, characteristics, and current issues. Reprod. Med. Biol., 2017, Vol. 16, no. 2, pp. 99-117.
补充文件
